The relative toxicity of disease‐modifying antirheumatic drugs

Arthritis & Rheumatism

Volumn 36, Issue 3, 1993, Pages 297-306

  Fries, James F ^a   Williams, Catherine A ^a   Ramey, Dena ^a   Bloch, Daniel A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; FENOPROFEN; GOLD; HYDROXYCHLOROQUINE; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PIROXICAM; PREDNISONE; SALSALATE; SULINDAC; TOLMETIN;

ARTICLE; BLOOD TOXICITY; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; NEPHROTOXICITY; NEUROTOXICITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN TOXICITY;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; COMPARATIVE STUDY; HUMAN; HYDROXYCHLOROQUINE; LONGITUDINAL STUDIES; METHOTREXATE; PENICILLAMINE; PREDNISONE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027415115     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.1780360303     Document Type: Article

References (19)

1. Remodeling the pyramid: a concept whose time has come (editorial)
2. Remodelling the pyramid: the therapeutic target of rheumatoid arthritis (editorial)
3. Rethinking rheumatic disease therapy (editorial)
4. Winning the battle, losing the war? Another editorial about rheumatoid arthritis
5. Reevaluation of the therapeutic approach to rheumatoid arthritis: the „sawtooth” strategy
6. Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use
7. NSAID‐associated gastropathy: incidence and risk factor models
8. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons
9. Nonsteroidal antiinflammatory drugs and peptic ulcer disease
10. NSAID induced ulcers: an emerging epidemic (editorial)
11. The ARAMIS (American Rheumatism Association Medical Information System) Post‐Marketing Surveillance Program
12. Measurement of patient outcome in arthritis
13. A toxicity index for comparison of side effects among different drugs
14. The relative toxicity of nonsteroidal antiinflammatory drugs
15. Empirical comparison of approaches to forming strata: using classification trees to adjust for covariates
16. Impact of specific therapy upon rheumatoid arthritis
17. The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis: results of two metaanalyses
18. Long‐term outcome of treating rheumatoid arthritis: results after 20 years
19. Rheumatoid arthritis: disappointing long‐term outcomes despite successful short‐term clinical trials